The Lung Cancer Screening Study, commonly referred to as I-ELCAP, is a non-experimental, investigational research study that seeks to assess the effectiveness of using low-dose, non-contrast Computed Tomography (CT) chest imaging as a screening tool in evaluating early stage lung cancer in people at high risk.

In 1992, a group of physicians from Cornell University Medical Center (now Weill Medical College of Cornell University) joined forces with specialists and lung cancer experts from around the world to develop a more accurate way to detect lung cancer in its earliest stage by using CT imaging. In 1993, the International Early Lung Cancer Action Program (I-ELCAP) was born. The mission of I-ELCAP is to achieve early diagnosis, treatment, and ultimate cure of lung cancer.

WellStar is proud to be participating in this investigational study.

Thinking About Quitting? Call the Georgia Tobacco Quit Line 
1-877-270-STOP (7867)
1-877-2NO-FUME (266-3863) Spanish Language
TTY: 1-877-6534 (Hearing Impaired)
http://health.state.ga.us/
programs/tobacco/index.asp
www.georgiacancer.org

WellStar Cancer Research
522 North Ave.
Marietta, Georgia 30060
678-594-4302
vickie.beckler@wellstar.org

www.ielcap.org
www.lungcanceralliance.org
www.cancer.org 
www.lungusa.org 
www.nih.gov 
www.georgiacancer.org
http://health.state.ga.us/
programs/tobacco/index.asp
www.smokefree.gov